Phosphodiesterase activity and regulation of phosphodiesterase 1-B-mediated signaling in brain

Details for Australian Patent Application No. 2002324846 (hide)

Owner The Rockefeller University Childrens Hospital Medical Center

Inventors Repaske, David; Greengard, Paul; Snyder, Gretchen

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002324846

PCT Number PCT/US02/27803

PCT Pub. Number WO2003/020702

Priority 60/316,320 31.08.01 US

Filing date 3 September 2002

Wipo publication date 18 March 2003

Acceptance publication date 10 May 2007

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/08 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 15/08 (2006.01) Drugs for genital or sexual disorders

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 25/30 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/44 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving esterase

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/316,320 31.08.01 US

5 June 2003 Application Open to Public Inspection

  Published as AU-B-2002324846

10 May 2007 Application Accepted

  Published as AU-B-2002324846

6 September 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002324847-DNA BINDING PROTEIN

2002324845-METHODS FOR IDENTIFYING HETEROZYGOUS CARRIERS OF AUTOSOMAL RECESSIVE DISEASES